# OnCo record nct07060365 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07060365/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07060365", "NCT07060365" ;
  schema:name "A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer"@en ;
  schema:description "This study tests a PARP inhibitor; the registry reports that it is withdrawn."@en ;
  schema:url <https://onco.cc/trials/nct07060365/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07060365> ;
  onco:status "withdrawn" ;
  onco:phase "1/2" ;
  schema:startDate "2025-09-02" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/saruparib/> .
